IP Library Patent Application 16986311
Patent Application
App. No. 16/986,311

DYES FOR ANALYSIS OF PROTEIN AGGREGATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/986,311
Abstract

Provided are dyes and compositions which are useful in a number of applications, such as the detection and monitoring protein aggregation, kinetic studies of protein aggregation, neurofibrillary plaques analysis, evaluation of protein formulation stability, and analysis of molecular chaperone activity.

Claims (16)

1 . A compound comprising the structure

wherein m and n are independently 1, 2 or 3;

wherein L is a linker arm comprising carbon, sulfur, oxygen, nitrogen, or any combination thereof;

wherein R 1 , R 2 , R 3 , R 4 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 19 , R 20 , R 21 and R 22 are independently hydrogen, halogen, amino, ammonium, nitro, sulfo, sulfonamide, carboxy, ester, cyano, phenyl, benzyl, an alkyl group wherein the alkyl group is saturated or unsaturated, linear or branched, substituted or unsubstituted, an alkoxy group wherein the alkoxy group is saturated or unsaturated, branched or linear, substituted or unsubstituted, or when taken in combination R 1 and R 2 , or R 3 and R 4 , or R 9 and R 10 , or R 11 and R 12 , or R 13 and R 14 , or R 15 and R 16 , or R 19 and R 20 , or R 21 and R 22 form a five or six membered ring wherein the ring is saturated or unsaturated, substituted or unsubstituted, and wherein R 9 and R 10 , or R 11 and R 12 , or R 13 and R 14 , or R 15 and R 16 can comprise alkyl chains that are joined together, wherein a quinoline moiety can be formed;

wherein R 7 , R 8 , R 17 and R 18 are independently hydrogen, Z, an alkyl group wherein the alkyl group is saturated or unsaturated, linear or branched, substituted or unsubstituted, an alkoxy group wherein the alkoxy group is saturated or unsaturated, branched or linear, substituted or unsubstituted, or when taken together, R 7 and R 8 and R 17 and R 18 , may form a 5 or 6 membered ring wherein the ring is saturated or unsaturated, substituted or unsubstituted;

wherein Z comprises a carboxyl group (CO 2 − ), a carbonate ester (COER 25 ), a sulfonate (SO 3 − ), a sulfonate ester (SO 2 ER 25 ), a sulfoxide (SOR 25 ), a sulfone (SO 2 CR 25 R 26 R 27 ), a sulfonamide (SO2NR 25 R 26 ), a phosphate (PO 4 = ), a phosphate monoester (PO 3 − ER 25 ), a phosphate diester (PO 2 ER 25 ER 26 ), a phosphonate (PO 3 = ) a phosphonate monoester (PO 2 − ER 25 ) a phosphonate diester (POER 25 ER 26 ), a thiophosphate (PSO 3 = ), a thiophosphate monoester (PSO 2 − ER 25 ) a thiophosphate diester (PSOER 25 ER 26 ), a thiophosphonate (PSO 2 = ), a thiophosphonate monoester (PSO − ER 25 ) a thiophosphonate diester (PSER 25 ER 26 ), a phosphonamide (PONR 25 R 26 NR 28 R 29 ), its thioanalogue (PSNR 25 R 26 NR 28 R 29 ), a phosphoramide (PONR 25 R 26 NR 27 NR 28 R 29 ), its thioanalogue (PSNR 25 R 26 NR 27 NR 28 R 29 ), a phosphoramidite (PO 2 R 25 NR 28 R 29 ) or its thioanalogue (POSR 25 NR 28 R 29 ) wherein E is independently O or S;

wherein R 25 , R 26 , R 27 , R 28 , and R 29 are independently a hydrogen, an unsubstituted straight-chain, branched or cyclic alkyl, alkenyl or alkynyl group, a substituted straight-chain, branched or cyclic alkyl, alkenyl or alkynyl group wherein one or more C, CH or CH 2 groups are substituted with an O atom, N atom, S atom, or NH group, or an unsubstituted or substituted aromatic group;

wherein Z is attached directly, or indirectly through a second linker arm comprising carbon, sulfur, oxygen, nitrogen, and any combinations thereof and wherein the second linker arm may be saturated or unsaturated, linear or branched, substituted or unsubstituted or any combinations thereof;

wherein R 5 , R 6 , R 23 and R 24 can independently be hydrogen or an alkyl group wherein the alkyl group is saturated or unsaturated, linear or branched, substituted or unsubstituted, or when taken in combination R 5 and R 6 or R 2 and R 5 or R 3 and R 6 or R 23 and R 24 or R 22 and R 23 or R 20 and R 24 form a five or six membered ring wherein the ring is saturated or unsaturated, substituted or unsubstituted; and

wherein said compound is modified to comprise a reactive group which is an isocyanate, isothiocyanate, monochlorotriazine, dichlorotriazine, 4,6,-dichloro-1,3,5-triazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, haloacetamide, aziridine, sulfonyl halide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imido ester, hydrazine, azidonitrophenol, azide, 3-(2-pyridyl dithio)-propionamide, glyoxal or aldehyde group.

2 . The compound of claim 1 , wherein the compound exhibits increased fluorescence in the presence of an aggregated form of a protein when compared to the fluorescence exhibited when the compound is in the presence of the unaggregated form of the protein.

3 . The compound of claim 1 , comprising the structure

modified to comprise the reactive group, or

modified to comprise the reactive group.

4 . The compound of claim 4 , wherein each of R 5 , R 6 , R 23 and R 24 are a methyl or an ethyl moiety.

5 . The compound of claim 1 , wherein the compound is S25, S43, TOL3, YAT2134, YAT2148, YAT2149, S13, YAT2135, YAT2324 or YAT2150, modified to comprise the reactive group.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2020
From: PATTON, WAYNE FORREST; PANDE, PRAVEEN; DAI, LIJUN; COLEMAN, JACK; YARMOLUK, SERGIY M.; KOVALSKA, VLADYSLAVA; VOLKOVA, KATERYNA; LOSYTSKYY, MYKHAYLO; BALANDA, ANATOLIY; LUDLAM, ANTHONY
To: ENZO BIOCHEM, INC.
Reel/Frame 053481/0489 →